Skip to main content
. 2022 Aug 22;114(11):1476–1483. doi: 10.1093/jnci/djac158

Figure 2.

Figure 2.

Percentages of estimated metastatic cancer cases (on January 1, 2018) who were initially diagnosed with metastasis (de novo) or who experienced recurrent metastatic disease after being initially diagnosed with early stage disease. Numbers above each bar represent total estimated metastatic prevalence for each cancer type.